CDH1 and neoplasm: For example, restoring the re-expression of the intracellular domain of E-cadherin in E-cadherin–deficient MDA-MB-231 cells promoted the transition of tumor cells from a motile phenotype to a sessile cellular phenotype, suggesting that E-cadherin is potential factor for the treatment of the breast cancer35.